Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients withβ-Thalassemia Intermedia

Iron overload in β-thalassemia intermedia

(2013) Khaled M. Musallam et al.   CURRENT OPINION IN HEMATOLOGY

 -Thalassemia Intermedia: A Clinical Perspective

(2013) K. M. Musallam et al.   Cold Spring Harbor Perspectives in Medicine

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study

(2012) A. T. Taher et al.   BLOOD

Contemporary approaches to treatment of beta-thalassemia intermedia

(2012) Ali T. Taher et al.   BLOOD REVIEWS

Optimal management of β thalassaemia intermedia

(2011) Ali T. Taher et al.   BRITISH JOURNAL OF HAEMATOLOGY

Real-World Use of Iron Chelators

(2011) J. L. Kwiatkowski   Hematology-American Society of Hematology Education Program

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

(2009) A. T. Taher et al.   BLOOD

Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies

(2009) Ali Taher et al.   BRITISH JOURNAL OF HAEMATOLOGY

Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia

(2009) Ali Taher et al.   BRITISH JOURNAL OF HAEMATOLOGY